Stratification of Nontuberculous Mycobacterial Disease Risk in Type 2 Diabetes Based on Metformin Use: a Population-Based Cohort Study in South Korea.
Hyeon Hwa KimSeonok KimMi-Ae KimChang Hee JungYoung Pil ChongTae Sun ShimYe-Jee KimKyung Wook JoPublished in: Antimicrobial agents and chemotherapy (2023)
In a 1:4 case-control matched analysis of data from a nationwide population-based cohort in South Korea, we evaluated whether metformin use mitigates the risk of nontuberculous mycobacterial disease in patients with type 2 diabetes. Multivariable analysis revealed no significant association of metformin use with a diminished risk for incident nontuberculous mycobacterial disease in patients with type 2 diabetes.